Lorimer C, Mills S, Chalmers A, Coombes I, Thompson G, Glendenning J
Neurooncol Pract. 2024; 11(4):413-420.
PMID: 39006523
PMC: 11241370.
DOI: 10.1093/nop/npae019.
Dagher R, Gad M, da Silva de Santana P, Sadeghi M, Yewedalsew S, Gujar S
J Neurooncol. 2024; 166(1):1-15.
PMID: 38212574
DOI: 10.1007/s11060-023-04528-8.
Kossmann M, Ehret F, Roohani S, Winter S, Ghadjar P, Acker G
Radiat Oncol. 2023; 18(1):198.
PMID: 38087368
PMC: 10717523.
DOI: 10.1186/s13014-023-02385-3.
Ninatti G, Pini C, Gelardi F, Sollini M, Chiti A
Cancers (Basel). 2023; 15(2).
PMID: 36672314
PMC: 9856914.
DOI: 10.3390/cancers15020364.
Bae W, Yee M, Song L, Canonico M, Verhoef P, Shimabukuro K
Perm J. 2022; 26(2):126-131.
PMID: 35933656
PMC: 9662259.
DOI: 10.7812/TPP/21.081.
Complications of Radiotherapy and Radiosurgery in the Brain and Spine.
Barisano G, Bergamaschi S, Acharya J, Rajamohan A, Gibbs W, Kim P
Neurographics (2011). 2022; 8(3):167-187.
PMID: 35388375
PMC: 8981962.
DOI: 10.3174/ng.1700066.
Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis.
Nichelli L, Casagranda S
Curr Opin Oncol. 2021; 33(6):597-607.
PMID: 34534142
PMC: 8528135.
DOI: 10.1097/CCO.0000000000000793.
Radiation-Induced Immunity and Toxicities: The Versatility of the cGAS-STING Pathway.
Constanzo J, Faget J, Ursino C, Badie C, Pouget J
Front Immunol. 2021; 12:680503.
PMID: 34079557
PMC: 8165314.
DOI: 10.3389/fimmu.2021.680503.
Differentiation of recurrent glioblastoma from radiation necrosis using diffusion radiomics with machine learning model development and external validation.
Park Y, Choi D, Park J, Ahn S, Kim H, Chang J
Sci Rep. 2021; 11(1):2913.
PMID: 33536499
PMC: 7858615.
DOI: 10.1038/s41598-021-82467-y.
Reduction of pTau and APP levels in mammalian brain after low-dose radiation.
Iacono D, Murphy E, Avantsa S, Perl D, Day R
Sci Rep. 2021; 11(1):2215.
PMID: 33500491
PMC: 7838187.
DOI: 10.1038/s41598-021-81602-z.
Radionecrosis and cellular changes in small volume stereotactic brain radiosurgery in a porcine model.
Zaer H, Glud A, Schneider B, Lukacova S, Hansen K, Adler J
Sci Rep. 2020; 10(1):16223.
PMID: 33004849
PMC: 7529917.
DOI: 10.1038/s41598-020-72876-w.
Radiation Necrosis in Intracranial Lesions.
Munier S, Ginalis E, Patel N, Danish S, Hanft S
Cureus. 2020; 12(4):e7603.
PMID: 32399337
PMC: 7212716.
DOI: 10.7759/cureus.7603.
Performance of Standardized Relative CBV for Quantifying Regional Histologic Tumor Burden in Recurrent High-Grade Glioma: Comparison against Normalized Relative CBV Using Image-Localized Stereotactic Biopsies.
Hoxworth J, Eschbacher J, Gonzales A, Singleton K, Leon G, Smith K
AJNR Am J Neuroradiol. 2020; 41(3):408-415.
PMID: 32165359
PMC: 7077911.
DOI: 10.3174/ajnr.A6486.
Radiation Induced Demyelination in Cervical Spinal Cord of the Head and Neck Cancer Patients after Receiving Radiotherapy.
H G, N S, O P G, R K T
J Biomed Phys Eng. 2020; 10(1):1-6.
PMID: 32158706
PMC: 7036413.
DOI: 10.31661/jbpe.v0i0.1055.
Multiple sclerosis as differential diagnosis of radionecrosis for post-irradiation brain lesions: A case report.
Guillemin F, Biau J, Conde S, Clavelou P, Dupic G
Clin Transl Radiat Oncol. 2020; 21:44-48.
PMID: 32021912
PMC: 6993054.
DOI: 10.1016/j.ctro.2020.01.001.
Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas.
Drumm M, Dixit K, Grimm S, Kumthekar P, Lukas R, Raizer J
Neuro Oncol. 2019; 22(4):470-479.
PMID: 31711239
PMC: 7158646.
DOI: 10.1093/neuonc/noz216.
Oligodendroglioma confers higher risk of radiation necrosis.
Ahmad H, Martin D, Patel S, Donahue J, Lopes B, Purow B
J Neurooncol. 2019; 145(2):309-319.
PMID: 31549281
DOI: 10.1007/s11060-019-03297-7.
Histopathologic quantification of viable tumor versus treatment effect in surgically resected recurrent glioblastoma.
Bagley S, Schwab R, Nelson E, Viaene A, Binder Z, Lustig R
J Neurooncol. 2018; 141(2):421-429.
PMID: 30446903
DOI: 10.1007/s11060-018-03050-6.
Diagnosis and Management of Radiation Necrosis in Patients With Brain Metastases.
Vellayappan B, Tan C, Yong C, Khor L, Koh W, Yeo T
Front Oncol. 2018; 8:395.
PMID: 30324090
PMC: 6172328.
DOI: 10.3389/fonc.2018.00395.
miRNA-based therapeutic potential of stem cell-derived extracellular vesicles: a safe cell-free treatment to ameliorate radiation-induced brain injury.
Leavitt R, Limoli C, Baulch J
Int J Radiat Biol. 2018; 95(4):427-435.
PMID: 30252569
PMC: 6433537.
DOI: 10.1080/09553002.2018.1522012.